<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-81190</identifier>
<setSpec>0034-9356</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Esmolol to control hemodynamic response during removal of a bilateral pheochromocytoma from a 10-year-old girl</dc:title>
<dc:description xml:lang="en">Pheochromocytomas, which derive from chromaffincells, can secrete catecholamines in large amounts. Theincidence of these tumors is low at 2 to 8 cases permillion population and only 10% of cases occur inchildren. A thorough understanding of thepathophysiology of these tumors and the consequenteffect of drugs will be necessary for treating thesepatients during the perioperative period. A great dealhas been published on drugs that can be used in thissetting, but only a small portion of the information isrelevant to children. Esmolol, a short-action -blocker,figures among the drugs that have been developed inrecent years. We report a case in which esmolol was usedduring surgery in a 10-year-old girl undergoingscheduled removal of a bilateral pheochromocytoma(AU)</dc:description>
<dc:creator>Rodríguez González, O</dc:creator>
<dc:creator>Martín Iglesias, A</dc:creator>
<dc:creator>Rodríguez Germa, I</dc:creator>
<dc:creator>Besada Estévez, J. C</dc:creator>
<dc:creator>Amador García, I</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Los feocromocitomas son tumores derivados de lascélulas cromafines, que pueden secretar grandes cantidadesde catecolaminas. Su incidencia es baja, 2-8 casospor millón de habitantes, solamente un 10% de éstos sedan en edad infantil. Para el tratamiento perioperatoriocorrecto se requiere un conocimiento profundo desu fisiopatología, y de la farmacología implicada. Haygran cantidad de información publicada sobre fármacosque pueden utilizarse pero no tan extensa en niños.En los últimos años se han ido desarrollando nuevosfármacos entre los que se encuentran el esmolol, unbeta bloqueante de acción corta. Presentamos un casode tratamiento intraoperatorio con esmolol en unapaciente de 10 años programada para la extirpación deun feocromocitoma bilateral(AU)</dc:description>
<dc:source>Rev Esp Anestesiol Reanim;57(7): 454-457, ago.-sept. 2010. ilus</dc:source>
<dc:identifier>ibc-81190</dc:identifier>
<dc:title xml:lang="es">Manejo hemodinámico intraoperatorio con esmolol durante la extirpación de un feocromocitoma bilateral en una paciente de 10 años</dc:title>
<dc:subject>^d11664^s22045</dc:subject>
<dc:subject>^d11664^s22074</dc:subject>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d7697^s22073</dc:subject>
<dc:subject>^d771^s22074</dc:subject>
<dc:subject>^d10868^s22016</dc:subject>
<dc:subject>^d20180^s22039</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d7594^s22045</dc:subject>
<dc:subject>^d10868^s22009</dc:subject>
<dc:subject>^d7594^s22039</dc:subject>
<dc:subject>^d30912^s22045</dc:subject>
<dc:subject>^d771^s22045</dc:subject>
<dc:subject>^d30912^s22066</dc:subject>
<dc:subject>^d6590^s22021</dc:subject>
<dc:subject>^d6590^s22031</dc:subject>
<dc:subject>^d7168^s22066</dc:subject>
<dc:type>article</dc:type>
<dc:date>201009</dc:date>
</metadata>
</record>
</ibecs-document>
